The Role of Serological and Tuberculosis Tests in the Diagnosis of Vertebral Osteomyelitis and the Medical Management of Paravertebral Involvement
Öz
ABSTRACT Objective: Vertebral osteomyelitis (VOM) is a bone tissue infection that is not often recognized but should be considered in cases of low back pain/back pain. This group of patients, who most commonly present with pain complaints, may sometimes have no complaints and may be diagnosed by chance during the examination. This is a rare but important disease group that is often missed. VOM may develop by hematogenous route, through neighborhood or after invasive procedures. Causative agents are often pyogenic bacteria (often gram-positive agents) and Mycobacterium tuberculosis. Although rare, VOM may develop due to fungal agents. Method: This study focused on 127 patients who were diagnosed with VOM in the last 5 years and whose treatment was completed with cure. In addition to the patients' demographics, diagnostic methods, involved joint, causative microorganism, initial clinical findings, pain levels (NRS-Numeric rating Scale), laboratory values, treatments received, treatment switch times, and treatment responses were recorded. Results: In our study, pyogenic bacteria group was found to be the most common agent among all VOM patients. In granulomatous VOMs, M. tuberculosis ranked first. In VOM caused by M. tuberculosis, C-reactive protein was found to be significantly higher and in VOM caused by pyogenic bacteria, sedimentation values were significantly higher. White blood cell count (WBC) and procalcitonin levels had low diagnostic value. Monthly follow-up of patients with contrast-enhanced MRI during the treatment period may be helpful in identifying the need for treatment revision. Paravertebral soft tissue involvement in patients with vertebral osteomyelitis was statistically more common in patients with brucellosis and tuberculous VOM. Conclusion: In patients with VOM, identification of the causative agent is not always possible. These patients are mostly treated empirically. Our study data will contribute to the diagnosis and treatment of VOM patients.
Anahtar Kelimeler
Destekleyen Kurum
Etik Beyan
Teşekkür
Kaynakça
- Gregori F, Grasso G, Iaiani G, Marotta N, Torregrossa F, Landi A. Treatment algorithm for spontaneous spinal infections: a review of the literature. J Craniovertebr Junction Spine. 2019;10(1):3-9. Crossref
- Eser O, Aslan A, Coşar M, Şahin Ö, Korkmaz S. Spontaneous cervical vertebral osteomyelitis: case report. Duzce Med J. 2008;2:34-36.
- Herren C, Jung N, Pishnamaz M, Breuninger M, Siewe J, Sobottke R. Spondylodiscitis: Diagnosis and Treatment Options. Dtsch Arztebl Int. 2017;114(51-52):875-882. Crossref
- Beronius M, Bergman B, Andersson R. Vertebral osteomyelitis in Göteborg, Sweden: a retrospective study of patients during 1990-95. Scand J Infect Dis. 2001;33(7):527-532. Crossref
- Calmenero JD, et al. Ann Rheum Dis. 1997;56:709-715.
- Müller EJ, Russe OJ, Muhr G. Osteomyelitis of the spine. Orthopade. 2004;33(3):305-315. Crossref
- Yoon SH, Chung SK, Kim K-J, Kim H-J, Jin YJ, Kim HB. Pyogenic vertebral osteomyelitis: identification of microorganism and laboratory markers used to predict clinical outcome. Eur Spine J. 2010;19(4):575-582. Crossref
- Mavrogenis AF, Papagelopoulos PJ, et al. Spondylodiscitis revisited. EFORT Open Rev. 2017;2(11):447-461. Crossref Lehovsky J. Pyogenic vertebral osteomyelitis/disc infection. Baillieres Best Pract Res Clin Rheumatol. 1999;13(1):59-75. Crossref
Ayrıntılar
Birincil Dil
İngilizce
Konular
Bulaşıcı Hastalıklar
Bölüm
Araştırma Makalesi
Yazarlar
Ali Kutta Çelik
*
0000-0002-0660-7482
Türkiye
Çiğdem Yalçın
0000-0002-4857-1975
Türkiye
Mustafa Uğuz
0000-0002-3245-2162
Türkiye
Fatih Erdem
0009-0001-1779-2468
Türkiye
Yayımlanma Tarihi
17 Mart 2026
Gönderilme Tarihi
2 Şubat 2026
Kabul Tarihi
16 Mart 2026
Yayımlandığı Sayı
Yıl 2026 Cilt: 9 Sayı: 1